Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCanal+ Regulatory News (CAN)

Share Price Information for Canal+ (CAN)

Share Price is delayed by 15 minutes
Get Live Data
275.80    0.00 (0.00%)
Bid:
0.00
Ask:
299.00
Spread: 23.00 (8.333%)
Market Cap: £2.70b
CAN Live PriceLast checked at - London Stock Exchange

Intraday Canal+ Share Chart

Stabilisation Notice-Canal + SA

26 Nov 2025 16:02

RNS Number : 1542J
Societe Generale SA
26 November 2025
 

26th November 2025

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Canal + SA.

Pre-stabilisation Period Announcement

 

Societe Generale (contact: Duane Elgey +44 20 3547 1528) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with [Commission Delegated Regulation (EU) 2016/1052 under the Market Abuse Regulation (EU/596/2014)][and] [the UK FCA Stabilisation Binding Technical Standards].

 

Securities

Issuer:

Canal + SA

Guarantor(s) (if any):

N/A

Aggregate nominal amount:

EUR 700m

Description:

Coupon: 4.625% , Annual, Act/Act, ICMA

Maturity: 3 December 2030 (5-year fixed)

Offer price:

99.904%

 

Stabilisation:

Stabilisation Manager(s)

SG CIB

Stabilisation period expected to start on

26/11/2025

Stabilisation period expected to end no later than

02/01/2026

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may overallot the securities to the extent permitted in accordance with applicable law.

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may overallot10 the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time11. Any stabilisation action or overallotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom12.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, [the UK] [any EEA Member State] before the publication of a prospectus in relation to the securities which has been approved by the competent authority in [the UK] [that Member State] in accordance with Regulation (EU) 2017/1129 [as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 201813] (the "[EU][UK] Prospectus Regulation") [(or which has been approved by a competent authority in another Member State and notified to the competent authority that Member State in accordance with the EU Prospectus Regulation)], this announcement and the offer are only addressed to and directed at persons in [the UK] [that Member State] who are qualified investors within the meaning of the [EU][UK] Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in [the UK] [that Member State]14.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STABFBFTMTMTBMA
Date   Source Headline
2nd Jun 20269:26 amRNSHolding(s) in Company
1st Jun 20265:27 pmRNSAPPOINTMENTS TO THE SUPERVISORY BOARD
29th May 20266:07 pmRNSResults of Combined Shareholders' General Meeting
27th May 20263:00 pmRNSHolding(s) in Company
18th May 20266:28 pmRNSPublication of the Final Information Memorandum
13th May 20266:28 pmRNS€700 MILLION BOND ISSUE SUCCESSFULLY PRICED
13th May 20264:00 pmRNSStabilisation Notice- CANAL+
13th May 20263:37 pmRNSConvening Brochure - Shareholders’ General Meeting
13th May 20268:58 amRNSStabilisation Notice- CANAL +
12th May 20265:17 pmRNSHolding(s) in Company
12th May 20267:05 amRNSSECONDARY INWARD LISTING ON THE JSE
11th May 20269:23 amRNSPOTENTIAL BOND TRANSACTION
28th Apr 20267:00 amRNSCANAL+ Q1 2026 Trading Update
17th Apr 20261:05 pmRNSDirector Declaration
20th Mar 20263:38 pmRNSDirector/PDMR Shareholding
17th Mar 20263:28 pmRNSDirector/PDMR Shareholding
17th Mar 20263:26 pmRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSAnnual Financial Report
17th Mar 20267:00 amRNSAnnual Financial Report
12th Mar 20264:14 pmRNSDirector/PDMR Shareholding
12th Mar 20264:11 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNS2025 FY Preliminary Results & Strategic Update
11th Mar 20267:00 amRNS2025 FY Preliminary Results & Strategic Update
5th Mar 20267:10 amRNSMCG RETIRES SHOWMAX AFTER COMPREHENSIVE REVIEW
27th Feb 20261:22 pmRNSDirector Declaration
12th Feb 20263:47 pmRNSHolding(s) in Company
11th Feb 20263:06 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSCANAL+ MULTICHOICE SYNERGIES UPDATE
28th Jan 20262:42 pmRNSHolding(s) in Company
26th Jan 20269:09 amRNSDate of communication on MCG acquisition synergies
23rd Jan 20264:44 pmRNSHolding(s) in Company
6th Jan 20264:02 pmRNSHolding(s) in Company
2nd Jan 20262:43 pmRNSHolding(s) in Company
2nd Jan 202610:40 amRNSHolding(s) in Company
2nd Jan 202610:37 amRNSHolding(s) in Company
2nd Jan 202610:09 amRNSTotal Voting Rights
19th Dec 202510:30 amRNSRESOLUTION OF FRENCH VAT DISPUTE
19th Dec 202510:30 amRNSRESOLUTION OF FRENCH VAT DISPUTE
18th Dec 20255:00 pmRNSSUCCESSFUL EUR 1.8 BILLION FINANCING AGREEMENT
18th Dec 20255:00 pmRNSSUCCESSFUL EUR 1.8 BILLION FINANCING AGREEMENT
11th Dec 20252:24 pmRNSPost-Stabilisation Notice- Canal +
8th Dec 20252:15 pmRNSTERMINATION OF MULTICHOICE JSE AND A2X LISTINGS
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:34 pmRNSPUBLICATION OF THE FINAL INFORMATION MEMORANDUM
1st Dec 20252:13 pmRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20255:21 pmRNSHolding(s) in Company
27th Nov 20257:00 amRNS€700 MILLION BOND ISSUE SUCCESSFULLY PRICED
27th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.